These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8315933

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms.
    Shavit L, Lifschitz MD, Epstein M.
    Kidney Int; 2012 May; 81(10):955-968. PubMed ID: 22336987
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hyperkalemia in diabetes mellitus.
    Uribarri J, Oh MS, Carroll HJ.
    J Diabet Complications; 1990 May; 4(1):3-7. PubMed ID: 2141843
    [Abstract] [Full Text] [Related]

  • 27. Hyperkalemia in end-stage renal disease: mechanisms and management.
    Allon M.
    J Am Soc Nephrol; 1995 Oct; 6(4):1134-42. PubMed ID: 8589279
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
    Blumberg A, Weidmann P, Shaw S, Gnädinger M.
    Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.
    Palmer BF.
    N Engl J Med; 2004 Aug 05; 351(6):585-92. PubMed ID: 15295051
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
    Radó JP, Boer P.
    Endokrinologie; 1979 Apr 05; 73(2):173-85. PubMed ID: 467373
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Use of partusisten in prevention of hyperkalemia in patients with chronic glomerulonephritis with initial forms of renal failure].
    Skinskiĭ IM, Komandenko MS, Shulutko BI, Zamoskovskaia GA.
    Klin Med (Mosk); 1991 Oct 05; 69(10):83-4. PubMed ID: 1766229
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Various aspects of disorders of water-electrolyte metabolism in chronic renal failure].
    Manitius A.
    Pol Arch Med Wewn; 1984 Mar 05; 71(3):183-93. PubMed ID: 6739321
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.